Characterization and proteomic profile of extracellular vesicles from peritoneal dialysis efflux

PLoS One. 2017 May 10;12(5):e0176987. doi: 10.1371/journal.pone.0176987. eCollection 2017.

Abstract

Peritoneal Dialysis (PD) is considered the best option for a cost-effective mid-term dialysis in patients with Chronic Renal Failure. However, functional failure of the peritoneal membrane (PM) force many patients to stop PD treatment and start haemodialysis. Currently, PM functionality is monitored by the peritoneal equilibration test, a tedious technique that often show changes when the membrane damage is advanced. As in other pathologies, the identification and characterization of extracellular vesicles (EVs) in the peritoneal dialysis efflux (PDE) may represent a non-invasive alternative to identify biomarkers of membrane failure. Using size-exclusion chromatography, we isolated EVs from PDE in a group of patients. Vesicles were characterized by the presence of tetraspanin markers, nanoparticle tracking analysis profile, cryo-electron microscopy and mass spectrometry. Here, we report the isolation and characterization of PDE-EVs. Based on mass spectrometry, we have found a set of well-conserved proteins among patients. Interestingly, the peptide profile also revealed remarkable changes between newly enrolled and longer-treated PD patients. These results are the first step to the identification of PDE-EVs based new markers of PM damage, which could support clinicians in their decision-making in a non-invasive manner.

MeSH terms

  • Adult
  • Aged
  • Biomarkers / analysis
  • Biomarkers / metabolism
  • Extracellular Vesicles / metabolism
  • Extracellular Vesicles / pathology*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Peritoneal Dialysis* / methods
  • Peritoneum / metabolism
  • Peritoneum / pathology*
  • Proteome / analysis*
  • Proteome / metabolism
  • Proteomics* / methods

Substances

  • Biomarkers
  • Proteome

Grants and funding

This work was supported by the PI16/00072 project, integrated in the National R + D + I and funded by the ISCIII and the European Regional Development Fund http://www.isciii.es), “Suport Grups de Recerca” programme of Generalitat de Catalunya (2014SGR804, Group REMAR, http://agaur.gencat.cat), Instituto de Salud Carlos III-Red de Investigación Renal (REDinREN) (RD16/0009 Feder Funds, http://www.isciii.es, http://redinren.org), and Fundació Cellex. MF is sponsored by the Beatriu de Pinós-B contract (2014BP B00118, http://agaur.gencat.cat) from Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR) – Generalitat de Catalunya. FEB is sponsored by the “Researchers Stabilization Program” from the Spanish “Sistema Nacional de Salud” (SNS- ISCIII, http://www.isciii.es) and “Direcció d’Estratègia i Coordinació” Catalan Health Department (CES07/015, http://salutweb.gencat.cat). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.